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Abstract
Background: The prevalence of genotypes of the 677C>T polymorphism for the MTHFR gene
varies among humans. In previous studies, we found changes in the genotypic frequencies of this
polymorphism in populations of different ages, suggesting that this could be caused by an increase
in the intake of folate and multivitamins by women during the periconceptional period. The aim was
to analyze changes in the allelic frequencies of this polymorphism in a Spanish population, including
samples from spontaneous abortions (SA).
Methods: A total of 1305 subjects born in the 20th century were genotyped for the 677C>T
polymorphism using allele specific real-time PCR with Taqman® probes. A section of our population
(n = 276) born in 1980–1989 was compared with fetal samples (n = 344) from SA of unknown
etiology from the same period.
Results: An increase in the frequency of the T allele (0.38 vs 0.47; p < 0.001) and of the TT
genotype (0.14 vs 0.24; p < 0.001) in subjects born in the last quarter of the century was observed.
In the 1980–1989 period, the results show that the frequency of the wild type genotype (CC) is
about tenfold lower in the SA samples than in the controls (0.03 vs 0.33; p < 0.001) and that the
frequency of the TT genotype increases in the controls (0.19 to 0.27) and in the SA samples (0.20
to 0.33 (p < 0.01)); r = 0.98.
Conclusion: Selection in favor of the T allele has been detected. This selection could be due to
the increased fetal viability in early stages of embryonic development, as is deduced by the increase
of mutants in both living and SA populations.
Background
The methylenetetrahydrofolate reductase enzyme
(MTHFR) catalyzes a reaction that produces 5-methyltet-
rahydrofolate (5-methylTHF), the methyl donor for
homocysteine in the synthesis of methionine. The
677C>T mutation of the MTHFR gene has been associated
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with a thermolabile enzyme with decreased activity that
may cause an increase in plasma homocysteine concentra-
tions [1] when folate status is poor. This polymorphism is
one of the most widely studied clinically relevant poly-
morphisms in humans, as it is related to cardiovascular
disease [2] and neural tube defects (NTD; 601634) [3].
A large number of studies have provided a broad overview
of the prevalence of the 677C>T polymorphism in differ-
ent human populations, showing that the distribution of
frequencies is diverse [4]. These differences have been also
observed between groups of different ages in the same
Spanish population (older and younger than 24 years) [5]
and in a Swiss population (older and younger than 60
years) [6], as well as in a Japanese population [7].
In some populations, such the Toscanians in Italy [8] and
Mexicans [9], the homozygous mutated genotype (TT) has
reached frequencies greater than 30%. On the other hand,
in Africans the frequency of the TT genotype is very low
(less than 1%) [10,11], but, in African-Americans, it has
already reached 2% [12]. Studies based on the distribu-
tion of genotypic and allelic frequencies of the 677C>T
polymorphism and the 1298A>C polymorphism in the
MTHFR gene in Israeli, Japanese and Ghanaian Africans
populations [13] concluded that the 677T mutation in the
MTHFR gene emerged as a founder haplotype with some
selective advantage. Recently, preliminary evidence of
genetic selection of this polymorphism related to folate
intake has been reported [14].
The aim of the present study is to analyze the changes in
frequencies of the 677C>T polymorphism during the 20th
century and particularly the evolution of the frequencies
during the decade of 1980–1989, by comparing the geno-
type frequencies between living subjects born in this
period versus samples of spontaneous abortions (SA) that
occurred during in the same time period.
Methods
Subjects
This study was approved by the Ethics Committee at the
University Hospital "Virgen de la Victoria" (Málaga). One
of the study groups consisted of 344 fetal tissue samples
from SA, obtained from the Department of Pathology of
the University Hospital Carlos Haya (Málaga). These sam-
ples were selected after checking the clinical history and
by the inclusion criteria of containing histologically con-
firmed fetal tissue collected in the 1980s from SA at less
than 3 months (11 ± 1.70 week) and of unknown etiol-
ogy. These fetal samples were compared with a control
population of 276 subjects born in the 1980s with an
average age of 22 ± 4.58.
Another population of subjects born in the south of Spain
in the 20th century were genotyped (1305 subjects, 697
women and 608 men) and divided into four groups
according to birth date: 1900 to 1925 (n = 206); 1926 to
1950 (n = 320), 1951 to 1975 (n = 408), 1976 to 2000 (n
= 371). Individuals were selected randomly from different
areas of the province of Malaga, in southern Spain, and
from different social statuses to avoid a selection bias. All
the selected individuals were Caucasian and residents of
the study area. The parents of all subjects included in the
study were also Caucasian and born in Spain. The possi-
bility of a founder effect or genetic drift was investigated
and rejected. All the selected individuals were also geno-
typed for an insertion/deletion polymorphism in the
angiotensin converting enzyme (ACE) gene and/or the
2756A>G polymorphism in the methionine synthase
gene (MTR), in order to determine whether or not our
adult and young populations were genetically homogene-
ous. No significant differences were observed in allelic or
genotypic frequencies for these genes between the differ-
ent groups.
The population studied was randomly selected according
to age. Subjects 0–12 years old were selected from dried
blood spots from neonatal screening papers; subjects 10–
24 years old were recruited from students in primary and
secondary schools and in university; subjects 25–50 years
old and >51 years old were recruited using their Andalusia
Health Service identity cards. After approval by the Uni-
versity Hospital Ethical Committee, all the subjects were
contacted, and, from those whose written consent was
obtained, 10 ml of blood was taken. The investigation in
this study conforms to the principles outlined in the Dec-
laration of Helsinki.
Genetic analysis
The fetal samples were extracted from the archived forma-
lin-fixed, paraffin-embedded tissue sections. Genomic
DNA was extracted from fetal tissue using the method
described by Coombs et al. (1999) [15]. Genomic DNA of
the second and third groups was extracted from peripheral
leukocytes using the AquaPure Genomic DNA Blood Kit
(Bio-Rad).
Genotyping was performed using Real Time PCR with
allele specific Taqman® probes and primers described by
Ulvik et al. (2001) [16] and the following optimized pro-
tocol for 45 cycles: 10 s – 94°C, 40 s – 54°C, 15 s – 72°C.
The PCR mix (25 μl total volume) consisted of 5 μl of
genomic DNA, 0.5 μl of sense primer, 0.62 μl of anti-sense
primer, 0.85 μl Taqman® probe FAM, 0.43 μl Taqman®
probe TET, 20 μl PCR-buffer iQ-SupermixTM (Bio-Rad)
(containing 100 mM KCl, 40 mM Tris-HCl, (pH 8.4) 1.6
mM dNTP (dATP, dCTP, dGTP and dTTP), iTaq® polymer-
ase (50 units/mL) and 6 mM MgCl2) and 17.75 μl H2O.BMC Medical Genetics 2008, 9:104 http://www.biomedcentral.com/1471-2350/9/104
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Statistical and mathematical analysis
All samples were genotyped, and the allelic and genotypic
frequencies were compared. Differences were analyzed
statistically using the chi-square test or Fisher's exact test.
Correlations are expressed using Pearson's coefficient (r).
Compliance of genotype distributions with Hardy-Wein-
berg (HW) equilibrium was evaluated by chi-square anal-
ysis. For all tests, a p-value < 0.05 was considered to be
statistically significant. Values are expressed as the mean ±
SD.
The genetic selection model was calculated for the evolu-
tion of the 677C>T genotypes. The genetic selection could
be classified as codominant or incompletely dominant
and directional with the heterozygous genotype having an
intermediate fitness. For this kind of selection, the most
appropriate mathematical model is dq = [spq(2hp+q-h)]/
[p2 + 2pq(1-hs) + q2 × (1-s)], where dq is the change of fre-
quency of the allele with lower fitness, s is the fraction of
that genotype lost to selection, h is the degree of domi-
nance (between 0, for no dominance and 1, for complete
dominance), and p is the frequency of the allele with
higher fitness.
Results
We analyzed the genotype frequencies of the 677C>T pol-
ymorphism in a population born during the 20th century.
A total of 1305 subjects were divided into four groups of
25 years according to birth date. The genotype frequencies
were compared between the four quarters of the century
and showed very significant changes (p < 0.001) in the
group born in the last quarter of the 20th century (1976–
2000), when compared to any of the other groups. The
changes show a decrease of the CC genotype and an
increase of the TT genotype in the last 25 years of the 20th
century. (Table 1)
Considering that each 25 year period corresponds to a
generation, allelic frequencies did not change during the
first 75 years of the century (HW equilibrium). However,
we found that allelic and genotypic frequencies for the
677C>T polymorphism in the last quarter of the century
are significantly different compared to the previous gener-
ation (1951–1975). The genotype frequencies in the last
quarter of the century are not the expected by a HW calcu-
lation using the allelic frequencies of the previous genera-
tion. This could be described as a consequence of genetic
selection found in this population, in the absence of other
causes. Applying the mathematical model described
above to our population, the calculated fitness (s) is 0.5,
and it can be predicted that both alleles will be approxi-
mately at a frequency of 50% in the next generation and
allele T will be at 90% after seven generations (Figure 1A).
Another possibility is that a scenario could be predicted in
which both alleles will have frequencies of about 50% in
the next generation and that they will maintain this stabil-
ity while conditions remain unchanged. (Figure 1B)
The comparison of the genotype frequencies between a
group of fetal samples from SA that occurred during the
1980–1989 decade and living subjects born in the same
decade showed significant differences in genotype fre-
quencies (p < 0.001). CC genotypes were almost absent in
abortion samples compared to living subjects (0.03 vs
0.33), while CT and TT genotypes were overrepresented in
the same group. When 3-year periods are studied in the
decade, we detected a significant increase of the mutated
subjects during the decade (CT p < 0.05; TT p < 0.01).
Allele frequencies showed the same pattern (p < 0.05).
Controls showed the same tendency but without statisti-
cal significance. (Table 2)
The evolution of genotype frequencies during the 1980–
1989 decade of the TT genotypes correlates well in both
living populations as well as fetal samples r = 0.98 (p =
0.11).
Discussion
Different reports show that the prevalence of the 677C>T
polymorphism of the MTHFR gene differs dramatically
among human populations. Evidence of this dynamism
Table 1: Distribution of C677T genotype frequencies in the 20th century.
Frequencies by date of birth
C677T-MTHFR
Genotype-Allele
1900–1925
(n = 206)
1926–1950
(n = 320)
1951–1975
(n = 408)
1976–2000
(n = 371)
%n %n %n % n
CC 0.393 81 0.394 126 0.37 151 0.299* 111
CT 0.495 102 0.488 156 0.49 200 0.461 171
TT 0.112 23 0.119 38 0.14 57 0.24** 89
C allele 0.641 264 0.638 408 0.615 502 0.53** 393
T allele 0.359 148 0.363 232 0.385 314 0.47** 349
Note: *p < 0.05; **p < 0.01 (significance values in the last quarter of the century are relative to any other quarter of the century)BMC Medical Genetics 2008, 9:104 http://www.biomedcentral.com/1471-2350/9/104
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Hypothetical evolution of the allelic frequencies of mthfr 677c>t polymorphism Figure 1
Hypothetical evolution of the allelic frequencies of mthfr 677c>t polymorphism. Panel A represents the observed 
evolution of the allelic frequencies in the 20th century (DATA) and the hypothetical evolution predicted by the mathematical 
selection model (calculated fitness: s = 0.5) (PRED). Panel B represents the evolution of the allelic frequencies in the 20th cen-
tury (DATA) and the hypothetical evolution based on an allelic balance dependent on folate abundance conditions.BMC Medical Genetics 2008, 9:104 http://www.biomedcentral.com/1471-2350/9/104
Page 5 of 7
(page number not for citation purposes)
can be observed in many reports: frequency variations
between populations that are geographically very close,
even in the same country [8]; changes found in the same
race or ethnic group such as Africans [10,11] and African-
Americans [12]; the high prevalence of the 677C>T poy-
morphism in populations with special nutritional fea-
tures such as Mexicans [9] and Japanese [13]; and changes
in frequencies between generations of the same popula-
tion, as has been observed in Spain [5], Switzerland [6]
and Japan [7].
There are numerous interpretations of this great diversity,
and most tend to be related to adaptation to external con-
ditions such as climate or nutritional status. Dependence
of folate degradation on skin pigmentation [17], nutri-
tional habits or human intervention periconceptional
periods could explain this genetic variation. Definitely,
external factors in combination with different levels of
MTHFR enzyme activity, conditioned by polymorphisms,
could influence the fetal viability of certain genotypes.
In 1998, we suggested the possibility of genetic selection
in Spain in favor of the mutants of the 677C>T polymor-
phism in the MTHFR gene based on the fact that treat-
ment with vitamins and folates during pregnancy
increased the viability of fetuses with the TT homozygous
genotype. This hypothesis was based on the increase in
the number of mutated individuals found in our popula-
tion since the mid-1970s [5] and the coincident increased
intake of vitamins and folate by pregnant women in Spain
[18,19]. In 2002, a new study found changes in genotype
frequencies for the 677C>T and 1298A>C polymorphisms
in different age groups. Total homocysteine (tHcy) levels
in plasma were also analyzed according to the different
genotype interactions [20]. That study hypothesized
about fetal viability and about a genetic selection model
on the basis of non-linkage disequilibrium between both
polymorphisms. Recently, a study with fetal and control
populations showed the strong influence of these poly-
morphisms, though mainly of the 677C>T polymor-
phism, on spontaneous early abortion [21]. In the present
study, significant changes in allelic and genotypic fre-
quencies are detected, as is Hardy-Weinberg disequilib-
rium, at the 677C>T polymorphism. We hypothesize that
there is a dynamic process of genetic selection that favors
the T allele. This process of selection started during the last
quarter of the 20th century, during which the frequency
for mutant homozygous (TT) rose significantly from 14%
to 24%. We propose that this increase in mutants is due to
the inclusion of an external factor that enhances mutant
fetal viability.
If we apply the mathematical model for dynamic selection
developed for diploid organisms with sexual reproduc-
tion, the T allele could reach to 90% in seven generations
in our population (Figure 1A). However, this model
assumes selection in a constant environment that applies
to all individuals in the population studied. In our case,
we suggest that the external factor is related to an increase
in folate and vitamin intake in women in periconcep-
tional period and does not affect to all individuals
[18,19]. We assume that prediction of a classic selection
model in this case is only theoretical.
On the basis of a competition between alleles in which an
environmental factor favors one allele versus the other,
the final result would be that predicted by the previous
mathematical model. However in this case, the environ-
ment is not selecting against the wild type allele but rather
allowing the survival of more mutated alleles. Therefore,
the expected result would be not a systematic increase of
the mutated allele but the creation of an allelic balance
dependent on vitamin and folate abundance conditions.
In this case, the mutation would have a lower influence
on fetal viability (Figure 1B).
The results showed an increase in mutated genotypes (CT
and TT) and a strong protection against abortion by the
wild type genotype (CC), which is practically non-existent
in the SA group. The frequency of the CC genotype shows
no change over the decade studied (1980–1989), which
indicates that folate does not exert a visible effect on this
Table 2: Allelic and genotypic frequency comparison between 
fetal and control groups.
C677T-MTHFR
Genotype-Allele
Frequencies by date of birth
82–84 85–87 88–90
Fetal Group (n = 110) (n = 129) (n = 105)
%n %n % n
CC 0.073** 8 0.008** 1 0.019** 2
CT 0.727** 80 0.705** 91 0.6*# 63
TT 0.2 22 0.287 37 0.381## 40
C allele 0.436** 96 0.36** 93 0.319**# 67
T allele 0.564** 124 0.64** 165 0.681**# 143
Control Group (n = 88) (n = 93) (n = 95)
%n %n % n
CC 0.33 29 0.301 28 0.305 29
CT 0.477 42 0.452 42 0.421 40
TT 0.193 17 0.247 23 0.274 26
C allele 0.568 100 0.527 98 0.516 98
T allele 0.432 76 0.473 88 0.484 92
Note: *p < 0.05; **p < 0.01 (significant values relative to controls). #p 
< 0.05; ##p < 0.01 (significant values relative to the 1982–1984 
period)BMC Medical Genetics 2008, 9:104 http://www.biomedcentral.com/1471-2350/9/104
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genotype. However, the frequency of the mutated allele
increases during this decade, especially in fetuses from
abortions, and this increase correlated with the increase of
the T allele in the control population. This finding sug-
gests that the effect of folate is crucial to viability during
the early stages of embryonic development, but, even with
folate, not all embryos will survive until birth.
In this population, the mutant allele with lower enzy-
matic activity has higher fitness than the wild type. In the
folate cycle, it can be observed that 5,10-methyleneTHF
availability may be important. 5,10-methyleneTHF is the
substrate for several reactions in the cycle, but two of them
(5-methylTHF and thymidilate synthesis) might be essen-
tial for embryo development in folate deficiency condi-
tions.
In both cases, complete or limited MTHFR activity will
produce higher or lower 5,10-methyleneTHF availability,
which might be an essential factor for embryo develop-
ment, such that a greater folate levels can compensate the
lower enzymatic activity of the mutant.
The implications of this polymorphism in nucleotide syn-
thesis have not yet been determined, but certain data,
such as high levels of uric acid found in mutated subjects
[22,23], suggest that there are different turnover rates
associated with different polymorphisms.
Conclusion
We suggest that there is genetic selection in our popula-
tion for the T allele of the MTHFR – 677C>T polymor-
phism, whose origin could be an increase in fetal viability
during the early stages of embryonic development
because of an increase in folate and vitamin intake by
women in the periconceptional period that began to be
established in Spain in the last quarter of the 20th century
[18,19]. Higher frequencies for the T allele and TT geno-
type in our population are observed in the living and SA
populations.
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